IRIS

Sfoglia per Rivista  HEPATOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 81 a 100 di 123
Titolo Data di pubblicazione Autore(i) File
Natural NS3, NS5A and NS5B HCV resistance is common in real practice, differently associated to HCV genotypes and response to NS5A inhibitors 1-gen-2016 Cento, V; Sorbo, Mc; Bertoli, A; Lenci, I; Polilli, E; Masetti, C; Gianserra, L; Teti, E; Biliotti, E; Magni, Cf; Aragri, M; Micheli, V; Melis, M; Nicolini, La; Marenco, S; Calvaruso, V; Paolucci, S; Baldanti, F; Morisco, F; Siciliano, M; Palitti, Vp; Andreone, P; Bruzzone, B; Coppola, N; Ruggiero, T; Lichtner, M; Menzaghi, B; Romagnoli, D; Iapadre, N; Di Maio, Vc; De Leonardis, F; Milana, M; Cacciatore, P; Pieri, A; Sarmati, L; Landonio, S; Gasbarrini, A; Puoti, M; Craxi, A; Vullo, V; Pellicelli, Am; Babudieri, S; Rizzardini, G; Taliani, G; Andreoni, M; Pasquazzi, C; Parruti, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
New horizons in hepatitis C antiviral therapy with direct-acting antivirals 1-gen-2013 Aghemo, A; De Francesco, R
NPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 1-gen-2010 Valenti, L. V. C.; Rumi, M.; Galmozzi, E.; Del Menico, B.; De Nicola, S.; Dongiovanni, P.; Maggioni, M.; Fracanzani, A. L.; Rametta, R.; Colombo, M.; Fargion, S. R.; Aghemo, A. M.
NS3 and NS5A genotypes variants correlate with slow or fast progression of HCV-related disease after liver transplantation: does the viral diversity play really a role on fibrosis progression? 1-gen-2012 Lenci, I; Cucchiarelli, S; Di Maio, C; Cento, V; Milano, M; Di Paolo, D; De Luca, F; Tisone, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
NS3, NS5A and NS5B Coevolution in Patients Experiencing Virological-Failure with First-Generation Protease Inhibitors 1-gen-2014 Di Maio, Vc; Cento, V; Di Paolo, D; De Leonardis, F; Manunta, Af; Micheli, V; Tontodonati, M; Bertoli, A; Antonucci, F; Nosotti, L; Magni, Cf; Vecchiet, J; Mura, Ms; Andreoni, M; Morisco, F; Spaziante, M; Caporaso, N; Parruti, G; Rizzardini, G; Babudieri, S; Taliani, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
NS3-resistance in advanced HCV patients treated with BOC/TRV-based therapy: impact on virological failure of baseline and early time points 1-gen-2013 Cento, V; Di Maio, Vc; Di Paolo, D; Armenia, D; Micheli, V; Tontodonati, M; Antonucci, Fp; Bellocchi, Mc; Bertoli, A; De Leonardis, F; Madeddu, G; Magni, C; Sarrecchia, C; Nosotti, L; Tortora, A; Di Biagio, A; Nicolini, La; Parruti, G; Babudieri, S; Rizzardini, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection 1-gen-2003 Trere, D.; Borzio, M.; Morabito, A.; Borzio, F.; Roncalli, M.; Derenzini, M.
Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir Plus Ribavirin in Daily Practice Hepatitis C Virus Genotype 1-or 4-Infected Patients with Compensated Cirrhosis 1-gen-2016 Petta, S; Marzioni, M; Russo, P; Aghemo, A; Alberti, A; Ascione, A; Antinori, A; Bruno, R; Bruno, S; Chirianni, A; Gaeta, Gb; Giannini, Eg; Merli, M; Messina, V; Montilla, S; Perno, Cf; Puoti, M; Raimondo, G; Rendina, M; Ceccherini-Silberstein, F; Villa, E; Zignego, Al; Pani, L; Craxi, A
The Optimal Ribavirin Dose for Patients Infected with Hepatitis C Virus Genotype 3: Should We Utilize More? 1-gen-2009 Aghemo, A; Rumi, Mg; Prati, Gm; Colombo, M
Oxygen free radical production in rat liver: Effect of different doses of ethanol on anoxia-reperfusion injury 1-gen-1999 Gasbarrini, A; Di Campli, C; Addolorato, G; Simoncini, M; Pasini, P; Armuzzi, A; Pola, T; Cavallari, A; Nardo, B; Pola, P; Roda, A; Gasbarrini, G
p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder : association with cancer progression and prognosis 1-gen-2000 Hui, A. M.; Li, X.; Shi, Y. Z.; Torzilli, G.; Takayama, T.; Makuuchi, M.
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C 1-gen-2011 Valenti, L. V. C.; Rumi, M.; Galmozzi, E.; Aghemo, A.; Del Menico, B.; De Nicola, S.; Dongiovanni, P.; Maggioni, M.; Fracanzani, A. L.; Rametta, R.; Colombo, M.; Fargion, S. R.
Pathologic diagnosis of early hepatocellular carcinoma : a report of the international consensus group for hepatocellular neoplasia 1-gen-2009 Kojiro, M.; Wanless, I. R.; Alves, V.; Badve, S.; Balabaud, C.; Bedosa, P.; Bhathal, P.; Bioulac-Sage P, P.; Brunt, E. M.; Burt, A. D.; Craig, J. R.; Dhillon, A.; Ferrell, L.; Geller, S. A.; Goodman, Z. D.; Gouw, A. S.; Guido, M.; Guindi, M.; Hytiroglou, P.; Kage, M.; Kondo, F.; Kudo, M.; Lauwers, G. Y.; Nakano, M.; Paradis, V.; Park, Y. N.; Quaglia, A.; Roncalli, M.; Roskams, T.; Ruebner, B.; Sakamoto, M.; Saxena, R.; Theise, N. D.; Thung, S.; Taniakos, D.
PERCUTANEOUS ETHANOL INJECTION (PEI) IN THE TREATMENT OF HCC IN CIRRHOSIS - LONG-TERM RESULTS IN 746 PATIENTS 1-gen-1994 Livraghi, T; Bolondi, L; Rapaccini, Gl; Salmi, A; Marin, G; Torzilli, G; Brunello, F; Giorgio, A; Desio, I; Lazzaroni, S; Zucchi, A
Prediagnostic Circulating Vitamin D Levels and Risk of Hepatocellular Carcinoma in European Populations: A Nested Case-Control Study 1-gen-2014 Fedirko, V; Duarte-Salles, T; Bamia, C; Trichopoulou, A; Aleksandrova, K; Trichopoulos, D; Trepo, E; Tjonneland, A; Olsen, A; Overvad, K; Boutron-Ruault, Mc; Clavel-Chapelon, F; Kvaskoff, M; Kuhn, T; Lukanova, A; Boeing, H; Buijsse, B; Klinaki, E; Tsimakidi, C; Naccarati, A; Tagliabue, G; Panico, S; Tumino, R; Palli, D; Bueno-de-Mesquita, Hb; Siersema, Pd; Peters, Ph; Lund, E; Brustad, M; Olsen, Ks; Weiderpass, E; Zamora-Ros, R; Sanchez, Mj; Ardanaz, E; Amiano, P; Navarro, C; Quiros, Jr; Werner, M; Sund, M; Lindkvist, B; Malm, J; Travis, Rc; Khaw, Kt; Stepien, M; Scalbert, A; Romieu, I; Lagiou, P; Riboli, E; Jenab, M
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study 1-gen-2022 D'Alessio, Antonio; Fulgenzi, Claudia Angela Maria; Nishida, Naoshi; Schönlein, Martin; von Felden, Johann; Schulze, Kornelius; Wege, Henning; Gaillard, Vincent E; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Sharma, Rohini; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J
Preneoplastic cellular changes in liver 1-gen-1998 Borzio, M; Roncalli, M; Trere, D; Derenzini, M.
Prevalence and Clinical Impact of Hepatitis E Virus in Immunosuppressed Patient after Liver Transplantation 1-gen-2015 De Nicola, S; Donato, Mf; Premoli, C; Lunghi, G; Bono, P; Manini, Ma; Lampertico, P; Malinverno, F; Monico, S; Reggiani, P; Colombo, M; Aghemo, A
Prospective study of dysplastic nodes in cirrhotic patients : correlation with CT vascular pattern 1-gen-2008 Iavarone, M.; Sangiovanni, A.; Ronchi, G.; Forzenigo, L. V.; Aghemo, A.; Lampertico, P.; Colombo, M.
Quality of life and everyday activities in patients with primary biliary cirrhosis 1-gen-2007 Selmi, C.; Gershwin, M. E.; Lindor, K. D.; Worman, H. J.; Gold, E. B.; Watnjik, M; Utts, J; Invernizzi, P; Kaplan, M. M.; Vierling, J. M.; Bowlus, C. L.; Silveira, M. G.; Bossi, I; USA PBC EPIDEMIOLOGY, Group
Mostrati risultati da 81 a 100 di 123
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile